Oncour Pharma, Inc.

États‑Unis d’Amérique

Commandez votre montre hebdomadaire Oncour Pharma, Inc.
Quantité totale PI 22
Rang # Quantité totale PI 68 504
Note d'activité PI 1,9/5.0    12
Rang # Activité PI 73 045

Brevets

Marques

14 0
5 0
3 0
0
 
Dernier brevet 2025 - Treatment of solid tumors with n...
Premier brevet 2011 - Modified immune-modulating parti...

Derniers inventions, produits et services

2023 Invention Modified immune-modulating particles. The current invention involves the surprising finding that...
Invention Immune-modifying nanoparticles for the treatment of inflammatory diseases. The current invention...
Invention Treatment of solid tumors with negatively charged particles. The present disclosure generally re...
Invention Treatment of solid tumors with negatively charged particles. The present disclosure generally rel...
2022 Invention Negatively charged particles for the treatment of inflammation-related burn injuries. The presen...
Invention Negatively charged particles for the treatment of inflammation-related burn injuries. The present...
2021 Invention Negatively charged particles for the treatment of cytokine storm syndrome (css) and acute respira...
2020 Invention Treatment of immune evasive tumors. The present disclosure provides methods of treating immune e...
2019 Invention Immune modifying particles for the treatment of cancer. The present disclosure provides methods ...
2018 Invention Modified immune-modulating particles. The presently claimed invention relates to methods of reduc...
Invention Immune-modifying nanoparticles for the treatment of inflammatory diseases. The current invention ...
2015 Invention Modified immune-modulating particles. The current invention involves the surprising finding that ...